Literature DB >> 24571881

Urodynamic analysis and treatment of male Parkinson's disease patients with voiding dysfunction.

Peng Xue1, Tao Wang1, Huantao Zong1, Yong Zhang2.   

Abstract

BACKGROUND: Parkinson's disease (PD) is an extrapyramidal neurological disorder. Urinary symptoms are frequently present in patients affected by PD. Symptoms such as urgency, frequency, nocturia, and urge incontinence significantly impact the patient's quality of life. We attempted to investigate the urodynamic changes and treatment of male PD patients with voiding dysfunction by means of a review.
METHODS: Comprehensive urodynamic examinations were performed in 141 male patients with PD associated with voiding dysfunction. Appropriate treatments were given to subgroups that were divided based on test results, and the changes in urodynamic parameters as well as the treatment efficacy were observed.
RESULTS: Detrusor hyperreflexia without bladder outlet obstruction (BOO) was observed in 35 patients, who exhibited significant improvements in the international prostate symptom score (IPSS), maximum flow rate (Qmax), bladder volume at the first desire to void, post-void residual (PVR), and bladder compliance. Detrusor hyperreflexia associated with BOO was observed in 59 patients. The patients exhibited significant improvements in IPSS, Qmax, PVR, and bladder compliance. Detrusor dysfunction without BOO was observed in 19 patients, for whom the IPSS and the bladder volume at the first desire to void were improved after treatment. Detrusor dysfunction with BOO was found in 28 patients, with no significant improvement in the urodynamic parameters after the treatment.
CONCLUSIONS: Urodynamic examination is recommended for male Parkinson's disease patients with voiding dysfunction. Early and effective treatment can improve the bladder function and quality of life of these patients.

Entities:  

Mesh:

Year:  2014        PMID: 24571881

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  8 in total

Review 1.  A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015.

Authors:  Lama M Chahine; Amy W Amara; Aleksandar Videnovic
Journal:  Sleep Med Rev       Date:  2016-08-31       Impact factor: 11.609

2.  Surgical outcome of male patients with chronic central nervous system disorders and voiding dysfunction due to bladder outlet obstruction.

Authors:  Tien-Lin Chang; Sheng-Fu Chen; Hann-Chorng Kuo
Journal:  Int Urol Nephrol       Date:  2022-07-11       Impact factor: 2.266

Review 3.  Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.

Authors:  Anne Pavy-Le Traon; Nikki Cotterill; Gerard Amarenco; Susanne Duerr; Horacio Kaufmann; Heinz Lahrmann; François Tison; Gregor K Wenning; Christopher G Goetz; Werner Poewe; Cristina Sampaio; Anette Schrag; Olivier Rascol; Pablo Martinez-Martin; Glenn T Stebbins
Journal:  Mov Disord Clin Pract       Date:  2018-10-25

Review 4.  Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.

Authors:  Santiago Pérez-Lloret; Daniel P Cardinali
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

5.  Nocturia in Patients With Parkinson's Disease.

Authors:  Matthew Smith; Jai Seth; Amit Batla; Johann Hofereiter; Kailash P Bhatia; Jalesh N Panicker
Journal:  Mov Disord Clin Pract       Date:  2015-12-24

Review 6.  Nocturia in Parkinson's Disease: Why Does It Occur and How to Manage?

Authors:  Amit Batla; Véronique Phé; Lorenzo De Min; Jalesh N Panicker
Journal:  Mov Disord Clin Pract       Date:  2016-06-07

Review 7.  Treatment Options for Urogenital Dysfunction in Parkinson's Disease.

Authors:  Amit Batla; Natalie Tayim; Mahreen Pakzad; Jalesh N Panicker
Journal:  Curr Treat Options Neurol       Date:  2016-10       Impact factor: 3.598

8.  Effect of Deep Brain Stimulation on Female Parkinsonian Patients with Lower Urinary Tract Symptoms.

Authors:  Fuchao Liang; Yueqing Tang; Kaipeng Bi; Xuchen Liu; Chao Li; Si Chen; Chao Zhang; Lei Yan; Zhonghua Xu; Ning Yang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-18       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.